Cromwell Holdings’s BioMarin Pharmaceuticals BMRN Stock Holding History

Cromwell Holdings’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.69K	Buy	47 +13	+38%	+$712	﹤0.01%	789
2026 Q1	$1.92K	Hold	34	–	–	﹤0.01%	724
2025 Q4	$2.02K	Hold	34	–	–	﹤0.01%	692
2025 Q3	$1.84K	Buy	34 +13	+62%	+$743	﹤0.01%	714
2025 Q2	$1.15K	Buy	21 +7	+50%	+$412	﹤0.01%	778
2025 Q1	$990	Buy	+14	New	+$942	﹤0.01%	658

Other funds holding BMRN

Assenagon Asset Management

Assenagon Asset Management Senningerberg, Luxembourg $77B AUM 50.57% 1-Year Est. Return

Covea Finance Paris, France $3.17B AUM 35.01% 1-Year Est. Return

Handelsbanken Fonder

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Generali Investments CEE Prague, Czech Republic $2.11B AUM 25.53% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

PensionDanmark Copenhagen O, Denmark $12B AUM

Inspirion Wealth Advisors Libertyville, Illinois $873M AUM 16.23% 1-Year Est. Return

Miller Global Investments Dallas, Texas $121M AUM

Woodstock Corp Boston, Massachusetts $1.2B AUM 26.37% 1-Year Est. Return

Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return